Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barten

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Medical Microbiology and Immunology|April 30, 2003
Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimodK Wenzel, B Saka, R Zimmermann, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 1, 1994
Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosaC Ostwald, P Müller, M Barten, et al.
Zeitschrift Fur Gastroenterologie|March 20, 2001
[Anisakiasis of the stomach--a case report from Germany]F Plath, A Holle, D Zendeh, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney diseaseThijs R M Barten, Lucas H P Bernts, Joost P H Drenth, et al.
Veterinary Pathology|July 5, 2007
Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit modelH Aupperle, J Garbade, A Schubert, et al.
Journal of Clinical Gastroenterology|August 23, 2022
Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of LifeRenée Duijzer, Thijs R M Barten, Christian B Staring, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 24, 2023
Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapyThijs R M Barten, Christian B Staring, Marie C Hogan, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant modelM H C Richter, H Richter, M Barten, et al.
Transplantation Proceedings|August 15, 2002
Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based studyM H C Richter, H Richter, M Barten, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Estrogens in polycystic liver disease: A target for future therapies?Sophie E Aapkes, Lucas H P Bernts, Thijs R M Barten, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Medical Microbiology and Immunology|April 30, 2003
Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimodK Wenzel, B Saka, R Zimmermann, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 1, 1994
Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosaC Ostwald, P Müller, M Barten, et al.
Zeitschrift Fur Gastroenterologie|March 20, 2001
[Anisakiasis of the stomach--a case report from Germany]F Plath, A Holle, D Zendeh, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney diseaseThijs R M Barten, Lucas H P Bernts, Joost P H Drenth, et al.
Veterinary Pathology|July 5, 2007
Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit modelH Aupperle, J Garbade, A Schubert, et al.
Journal of Clinical Gastroenterology|August 23, 2022
Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of LifeRenée Duijzer, Thijs R M Barten, Christian B Staring, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 24, 2023
Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapyThijs R M Barten, Christian B Staring, Marie C Hogan, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant modelM H C Richter, H Richter, M Barten, et al.
Transplantation Proceedings|August 15, 2002
Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based studyM H C Richter, H Richter, M Barten, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Estrogens in polycystic liver disease: A target for future therapies?Sophie E Aapkes, Lucas H P Bernts, Thijs R M Barten, et al.
Pageof 10